ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Pfizer Inc. (PFE), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live PFE chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
62.6B
YoY-1.6%
63.6B
YoY+25.0%
50.9B
YoY-44.5%
91.8B
YoY+24.7%
73.6B
YoY+76.8%
Cost of revenue
16.1B
YoY-10.0%
17.9B
YoY-28.5%
25.0B
YoY-27.3%
34.3B
YoY+11.4%
30.8B
YoY+263.3%
Research & development
10.4B
YoY-3.6%
10.8B
YoY+1.3%
10.7B
YoY-6.6%
11.4B
YoY+10.3%
10.4B
YoY+19.0%
Selling, general & administrative
13.8B
YoY-6.4%
14.7B
YoY-0.3%
14.8B
YoY+8.0%
13.7B
YoY+7.7%
12.7B
YoY+9.5%
Restructuring
1.09B
YoY-45.0%
1.99B
YoY+1.0%
1.97B
YoY+123.1%
882M
YoY+19.0%
741M
YoY+38.5%
Amortization of intangibles
5.30B
YoY+12.8%
4.70B
YoY+30.6%
3.60B
YoY-2.7%
3.70B
YoY+8.8%
Interest expense
2.67B
YoY-13.6%
3.09B
YoY+39.9%
2.21B
YoY+78.4%
1.24B
YoY-4.1%
1.29B
YoY-10.9%
Interest & investment income
603M
YoY+10.6%
545M
YoY-66.4%
1.62B
YoY+547.0%
251M
YoY+597.2%
36.0M
YoY-50.7%
Other non-operating income
-6.72B
YoY-53.2%
-4.39B
YoY-1876.6%
-222M
YoY+79.1%
-1.06B
YoY-121.8%
4.88B
YoY+502.1%
Pre-tax income
7.52B
YoY-6.3%
8.02B
YoY+658.3%
1.06B
YoY-97.0%
34.7B
YoY+42.9%
24.3B
YoY+245.5%
Income tax
-266M
YoY-850.0%
-28.0M
YoY+97.5%
-1.11B
YoY-133.5%
3.33B
YoY+79.7%
1.85B
YoY+400.5%
7.77B
YoY-3.2%
8.03B
YoY+279.0%
2.12B
YoY-93.2%
31.4B
YoY+42.7%
22.0B
YoY+140.0%
$1.36
YoY-3.5%
$1.41
YoY+281.1%
$0.37
YoY-93.2%
$5.47
YoY+42.1%
$3.85
YoY+136.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
42.9B
YoY-14.8%
50.4B
YoY+16.2%
43.3B
YoY-15.5%
51.3B
YoY-14.1%
59.7B
YoY+70.2%
208B
YoY-2.5%
213B
YoY-5.8%
227B
YoY+14.9%
197B
YoY+8.7%
181B
YoY+17.7%
37.0B
YoY-14.0%
43.0B
YoY-10.0%
47.8B
YoY+13.4%
42.1B
YoY-1.2%
42.7B
YoY+64.6%
121B
YoY-2.8%
125B
YoY-9.0%
137B
YoY+35.5%
101B
YoY-2.6%
104B
YoY+14.6%
86.5B
YoY-2.0%
88.2B
YoY-0.9%
89.0B
YoY-6.9%
95.7B
YoY+23.9%
77.2B
YoY+22.1%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
11.7B
YoY-8.2%
12.7B
YoY+46.5%
8.70B
YoY-70.3%
29.3B
YoY-10.2%
32.6B
YoY+126.2%
-1.35B
YoY-150.9%
2.65B
YoY+108.2%
-32.3B
YoY-104.5%
-15.8B
YoY+30.0%
-22.5B
YoY-427.9%
-10.3B
YoY+39.9%
-17.1B
YoY-165.8%
26.1B
YoY+275.7%
-14.8B
YoY-51.1%
-9.82B
YoY-1.7%
FX effect on cash
41.0M
YoY+162.1%
-66.0M
YoY-65.0%
-40.0M
YoY+75.8%
-165M
YoY-179.7%
-59.0M
YoY-637.5%
Net change in cash
91.0M
YoY+105.0%
-1.81B
YoY-173.9%
2.45B
YoY+261.6%
-1.51B
YoY-1052.8%
159M
YoY-66.5%
Interest paid
2.74B
YoY-15.1%
3.23B
YoY+45.7%
2.21B
YoY+53.6%
1.44B
YoY-1.7%
1.47B
YoY-10.6%
Income taxes paid
4.69B
YoY+30.0%
3.60B
YoY+14.6%
3.15B
YoY-60.0%
7.87B
YoY+5.9%
7.43B
YoY+135.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
142B
YoY-5.8%
150B
YoY-7.5%
163B
YoY-43.5%
288B
YoY-13.2%
331B
YoY+62.0%
P/E
18.2×
YoY-2.7%
18.7×
YoY+20.7%
15.5×
YoY+60.5%
9.7×
YoY-35.9%
15.1×
YoY-32.5%
P/S
2.3×
YoY-4.3%
2.4×
YoY-11.7%
2.7×
YoY-14.2%
3.1×
YoY-30.7%
4.5×
YoY-8.4%
P/B
1.6×
YoY-4.0%
1.7×
YoY+1.6%
1.7×
YoY-46.0%
3.1×
YoY-27.7%
4.3×
YoY+32.7%
P/FCF
15.6×
YoY+2.1%
15.3×
YoY-23.1%
19.9×
YoY+61.5%
12.3×
YoY+10.9%
11.1×
YoY-34.0%
Earnings yield
5.5%
YoY+2.8%
5.3%
YoY-17.2%
6.4%
YoY-37.7%
10.4%
YoY+56.1%
6.6%
YoY+48.1%
FCF yield
6.4%
YoY-2.0%
6.5%
YoY+30.0%
5.0%
YoY-38.1%
8.1%
YoY-9.9%
9.0%
YoY+51.4%
Dividend yield
6.9%
YoY+8.4%
6.4%
YoY+11.1%
5.7%
YoY+82.4%
3.1%
YoY+18.2%
2.7%
YoY-36.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: PFE's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PFE filings on SEC EDGAR → Not investment advice.